Data Capture International, Inc. Appoints Deborah Rucker To Vice President, Business Development

MARIETTA, Ga., Jan. 10 /PRNewswire/ -- Data Capture International, Inc. (DCI), an emerging Application Service Provider that offers Electronic Data Capture (EDC) software solutions and services to pharmaceutical companies and Contract Research Organizations (CRO’s) that perform Phase I (early stage) human clinical trials, announced the appointment of Deborah A. Rucker to Vice President, Business Development. In this position, Ms. Rucker will be initially responsible for leading DCI’s commercial efforts to promote the launch of the latest release of its flagship product, SureLynx(TM) Version 2.0.

Ms. Rucker has over 10 years of experience in the pharmaceutical industry, including 8 years of senior management at pharmaceutical services organizations. Ms. Rucker is also a co-founder of Tricon Pharmaceuticals, an emerging product based pharmaceutical company. Her most recent pharmaceutical experience was with MDS Pharma Services, a leading global CRO, where she served as Vice President, Business Development for over 4 years.

“We are excited that Debi has joined DCI. Her in-depth knowledge and experience in growing pharmaceutical services organizations will be invaluable as we embark on the next stage of our commercialization strategy with the launch of SureLynx Version 2.0,” said Troy W. McCall, Ph.D., President and Chief Executive Officer. Dr. McCall continued, “Debi has demonstrated throughout her career an exceptional ability to grow emerging companies, and we fully anticipate that she will do the same at DCI.”

Ms. Rucker commented, “I am pleased to join DCI at such an exciting time. I have spent considerable time reviewing the company’s product and service offerings and am confident that we are poised to become leaders in our industry.”

Company Background

Data Capture International, Inc. (DCI) was founded to enhance pharmaceutical development by providing value-added software solutions and services for Phase I clinical trials. The company’s mission is to be the leading provider of automated identification and data capture technology and systems supporting pharmaceutical product development.

Data Capture International, Inc.

CONTACT: Troy W. McCall, Ph.D., President and CEO of Data CaptureInternational, Inc., +1-404-384-0145, or tmccall@datacaptureintl.com

MORE ON THIS TOPIC